- Home
- ACHV vs MHLD Comparison
ACHV vs MHLD Comparison
Compare ACHV & MHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- MHLD
- Stock Information
- Founded
- ACHV N/A
- MHLD 2007
- Country
- ACHV Canada
- MHLD Bermuda
- Employees
- ACHV N/A
- MHLD N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MHLD Property-Casualty Insurers
- Sector
- ACHV Health Care
- MHLD Finance
- Exchange
- ACHV Nasdaq
- MHLD Nasdaq
- Market Cap
- ACHV 149.6M
- MHLD 159.6M
- IPO Year
- ACHV N/A
- MHLD 2008
- Fundamental
- Price
- ACHV $4.33
- MHLD $1.67
- Analyst Decision
- ACHV Strong Buy
- MHLD
- Analyst Count
- ACHV 5
- MHLD 0
- Target Price
- ACHV $14.80
- MHLD N/A
- AVG Volume (30 Days)
- ACHV 116.0K
- MHLD 81.8K
- Earning Date
- ACHV 11-07-2024
- MHLD 11-12-2024
- Dividend Yield
- ACHV N/A
- MHLD N/A
- EPS Growth
- ACHV N/A
- MHLD N/A
- EPS
- ACHV N/A
- MHLD N/A
- Revenue
- ACHV N/A
- MHLD $89,074,000.00
- Revenue This Year
- ACHV N/A
- MHLD N/A
- Revenue Next Year
- ACHV N/A
- MHLD N/A
- P/E Ratio
- ACHV N/A
- MHLD N/A
- Revenue Growth
- ACHV N/A
- MHLD 20.80
- 52 Week Low
- ACHV $3.03
- MHLD $1.19
- 52 Week High
- ACHV $5.98
- MHLD $2.55
- Technical
- Relative Strength Index (RSI)
- ACHV 40.62
- MHLD 47.58
- Support Level
- ACHV $4.12
- MHLD $1.57
- Resistance Level
- ACHV $4.46
- MHLD $1.69
- Average True Range (ATR)
- ACHV 0.24
- MHLD 0.11
- MACD
- ACHV -0.05
- MHLD -0.01
- Stochastic Oscillator
- ACHV 17.65
- MHLD 31.71
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About MHLD Maiden Holdings Ltd.
Maiden Holdings Ltd provides reinsurance products and services to regional and specialty property and casualty insurers. The company operates in two segments: AmTrust Reinsurance and Diversified Reinsurance. The AmTrust Reinsurance segment provides products that cover workers' compensation, commercial package, commercial auto, and extended warranty. The Diversified Reinsurance segment provides small and midsize regional and specialty insurers with reinsurance capital products. Its revenues also include fee income earned from both its GLS business and IIS business as well as income generated from its investment portfolio.